A complete Pre-Seed financial model for Healthcare Biotech startups. Revenue model, unit economics, hiring plan, cash flow projections, and funding scenarios — structured for investor review.
Projection Horizon
18 months
Model Tabs
5 core tabs
Format
Excel + Google Sheets
Cash runway, burn rate, and the key milestones that unlock your next round. Pre-seed investors focus on whether you have enough runway to prove the thesis.
Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts.
Build every assumption from first principles. Pre-seed investors will ask "how did you get to this number?" for every major line. Have a clear answer that ties back to market research or comparable benchmarks.
Model two scenarios: (1) raising your target amount, (2) raising 70% of target. Show what milestones you hit in each case and when you need to start the next raise.
A Pre-Seed Healthcare Biotech financial model should cover 18 months of projections with these tabs: Assumptions Dashboard, Revenue Model (monthly), Headcount Plan, Cash Flow Forecast, Runway Sensitivity. Cash runway, burn rate, and the key milestones that unlock your next round. Pre-seed investors focus on whether you have enough runway to prove the thesis.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts. The key revenue drivers are: Patient volume x reimbursement rate by payer class; Commercial payer revenue (higher reimbursement); Medicare/Medicaid revenue (standardized rates); Enterprise health system contract revenue.
Healthcare Biotech unit economics at the Pre-Seed stage should include: Revenue per patient by payer type; Cost to serve per patient (clinical + overhead); Contribution margin per patient at break-even; Patient acquisition cost via provider referral; Prior authorization denial rate and cost impact. Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Build every assumption from first principles. Pre-seed investors will ask "how did you get to this number?" for every major line. Have a clear answer that ties back to market research or comparable benchmarks. Start with the smallest unit of your business (one customer, one transaction, one seat) and build up from there. Every assumption should have a source or benchmark you can defend in an investor meeting.
Model two scenarios: (1) raising your target amount, (2) raising 70% of target. Show what milestones you hit in each case and when you need to start the next raise.
Get the Healthcare Biotech Pre-Seed financial model as a pre-built Excel and Google Sheets template. Assumptions dashboard, revenue model, unit economics, and cash flow — ready to customize.
Includes Excel file, Google Sheets version, and model documentation guide